RecruitingNot ApplicableNCT05530512
Acupuncture Therapy and Hypertension
Neuroimmune Mechanisms Underlying Electroacupuncture Effect on Vascular Function
Sponsor
University of California, Irvine
Enrollment
72 participants
Start Date
Jan 1, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
Acupuncture therapy will be provided to reduce blood pressure in hypertensive patients. The mild to moderate hypertensive patients will be either on or off hypertensive medications. The course last for 8 weeks and the frequency is once a week.
Eligibility
Min Age: 45 YearsMax Age: 75 Years
Inclusion Criteria3
- Subjects from 45 to 75 years of age
- Clinically diagnosed with mild to moderate hypertension and ON or OFF medication (Office SBP \> 140 mmHg and \< 160 mmHg Or ABPM average SBP \> 130 mmHg and \< 145 mmHg), and
- No significant ECG change reflecting ischemia (i.e. ST elevation or depression) at rest will be recruited to participate in this study.
Exclusion Criteria4
- Subjects will be excluded if pregnant or nursing.
- Subjects will be excluded if they have coronary disease (by history or on ECG screening), conduction abnormalities on ECG consistent with left bundle branch block, cardiac arrhythmias associated with low blood pressure (\<90 mmHg), peripheral vascular disease, orthopedic disease, diabetic neuropathy or severe hypertension (BP \>170 mmHg systolic or \>110 mmHg diastolic), or any other physical or psychological illness.
- Those with known sensitivity to any topical preparations or strong reactions to medical dressings and skin tapes also will be excluded.
- Inability our or unwillingness of individual to give written informed consent.
Interventions
OTHERelectroacupuncture
acupuncture needling and stimulation are applied for 30 min
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05530512